Hematology NewsPegylated interferon alfa-2a induces durable responses in MPNsApril 19, 2017AMLBleeding Disorders
Hematology NewsNew diagnostic tool identifies severe ADAMTS13 deficiencyApril 18, 2017ThrombosisRare DiseasesBleeding Disorders
Hematology NewsSafety of N9-GP for hemophilia B needs further study, FDA committee agreesApril 5, 2017Bleeding DisordersRare Diseases
Hematology TimesDrug granted fast track designation for PNHApril 1, 2017AnemiaThrombosisPharmacyBleeding Disorders
Hematology NewsReplacement factors, bypassing agents safely manage fitusiran bleed eventsMarch 13, 2017Bleeding Disorders
Hospital Physician: Hematology/OncologyHemophilia A and B: An OverviewMarch 1, 2017Bleeding Disorders
Hematology NewsSpecific polymorphisms excluded in hemophilic arthropathyFebruary 13, 2017Bleeding Disorders
Hematology NewsLow inhibitor incidence seen with new generation rhFVIIIFebruary 13, 2017Bleeding Disorders
Hematology NewsStudy highlights importance of genotyping in von Willebrand diseaseFebruary 12, 2017Bleeding Disorders
Hematology NewsBoys with severe hemophilia have good physical functionFebruary 12, 2017Bleeding DisordersPediatrics
Hematology NewsITI protects against bleeding in hemophilia A with factor VIII inhibitorsFebruary 11, 2017Bleeding Disorders
Hematology NewsStudy: No link between vaccines, inhibitor developmentFebruary 11, 2017Bleeding DisordersPediatrics
